Surface characteristics and biocompatibility of lactide-based poly(ethylene glycol) scaffolds for tissue engineering.

Novel lactide-based poly(ethylene glycol) (PEG) polymer networks (GL9-PEGs) were prepared by UV copolymerization of a glycerol-lactide triacrylate (GL9-Ac) with PEG monoacrylate (PEG-Ac) to use as scaffolds in tissue engineering, and the surface properties and biocompatibility of these networks were investigated as a function of PEG molecular weight and content. Analysis by ATR-FTIR and ESCA revealed that PEG was incorporated well within the GL9-PEG polymer networks and was enriched at the surfaces. From the results of SEM, AFM, and contact angle analyses, GL9-PEG networks showed relatively rough and irregular surfaces compared to GL9 network, but the mobile PEG chains coupled at their termini were readily exposed toward the aqueous environment when contacting water such that the surfaces became smoother and more hydrophilic. This reorientation and increase in hydrophilicity were more extensive with increasing PEG molecular weight and content. As compared to GL9 network lacking PEG, protein adsorption as well as platelet and S. epidermidis adhesion to GL9-PEG networks were significantly reduced as the molecular weight and content of PEG was increased, indicating that GL9-PEG networks are more biocompatible than the GL9 network due to PEG's passivity. Based on the physical and biological characterization reported, the GL9-PEG materials would appear to be interesting candidates as matrices for tissue engineering.

[1]  Jeffrey A. Hubbell,et al.  Synthesis of Polymer Network Scaffolds from l-Lactide and Poly(ethylene glycol) and Their Interaction with Cells , 1997 .

[2]  J. H. Lee,et al.  Plasma protein adsorption and platelet adhesion onto comb-like PEO gradient surfaces. , 1994, Journal of biomedical materials research.

[3]  Jeffrey A. Hubbell,et al.  Lactide-based poly(ethylene glycol) polymer networks for scaffolds in tissue engineering. , 1996 .

[4]  G. Ryu,et al.  Plasma protein adsorption to sulfonated poly(ethylene oxide)-grafted polyurethane surface. , 1996, Journal of biomedical materials research.

[5]  H. Kawakami,et al.  Inhibition of bacterial adhesion and biofilm formation by a heparinized hydrophilic polymer. , 1995, ASAIO journal.

[6]  Jeffrey A. Hubbell,et al.  Biomaterials in Tissue Engineering , 1995, Bio/Technology.

[7]  R M Nerem,et al.  Tissue engineering: from biology to biological substitutes. , 1995, Tissue engineering.

[8]  Young Ha Kim,et al.  Surface structure and inert surface characteristics of perfluorodecanoic acid‐grafted polyurethane , 1993 .

[9]  Jeffrey A. Hubbell,et al.  Bioerodible hydrogels based on photopolymerized poly(ethylene glycol)-co-poly(.alpha.-hydroxy acid) diacrylate macromers , 1993 .

[10]  J. Feijen,et al.  A new gas discharge process for preparation of non-fouling surfaces on biomaterials , 1993 .

[11]  J. Vacanti,et al.  Tissue engineering : Frontiers in biotechnology , 1993 .

[12]  Kinam Park,et al.  Surface modification of polymeric biomaterials with poly(ethylene oxide), albumin, and heparin for reduced thrombogenicity. , 1993, Journal of biomaterials science. Polymer edition.

[13]  D. Han,et al.  Preparation and surface properties of PEO-sulfonate grafted polyurethanes for enhanced blood compatibility. , 1993, Journal of biomaterials science. Polymer edition.

[14]  T. Okano,et al.  Blood compatibility of SPUU-PEO-heparin graft copolymers. , 1992, Journal of biomedical materials research.

[15]  K. Park,et al.  Synthesis of photoreactive poly(ethylene glycol) and its application to the prevention of surface-induced platelet activation. , 1992, Journal of biomedical materials research.

[16]  J. Hubbell,et al.  Surface-immobilized polyethylene oxide for bacterial repellence. , 1992, Biomaterials.

[17]  D. Han,et al.  Negative cilia concept for thromboresistance: synergistic effect of PEO and sulfonate groups grafted onto polyurethanes. , 1991, Journal of biomedical materials research.

[18]  J. H. Lee,et al.  Surface properties of copolymers of alkyl methacrylates with methoxy (polyethylene oxide) methacrylates and their application as protein-resistant coatings. , 1990, Biomaterials.

[19]  A. Abuchowski,et al.  The clinical efficacy of poly(ethylene glycol)-modified proteins , 1990 .

[20]  J. Andrade,et al.  Plasma Protein Adsorption: The Big Twelve a , 1987, Annals of the New York Academy of Sciences.

[21]  T. Okano,et al.  Surfaces and Blood Compatibility Current Hypotheses , 1987 .

[22]  J. Andrade Surface and Interfacial Aspects of Biomedical Polymers , 1985 .

[23]  H. O. Senekjian,et al.  Gram Negative Peritonitis , 1983, The International journal of artificial organs.

[24]  J. Andrade,et al.  Surface oxidation of cis–trans polybutadiene , 1982 .

[25]  Y Noishiki,et al.  A new antithrombogenic material with long polyethyleneoxide chains. , 1982, Transactions - American Society for Artificial Internal Organs.